HHL ETF Analysis: Harvest Healthcare Leaders | TO

Healthcare Equity | TO, Canada | Market Cap: 1.976m CAD | 12M Return: 16.5% | CA41755F1071 | Charts, Fundamentals & Technical Analysis

Pharmaceuticals, Biotechnology, Medical Devices, Healthcare Providers
Total Rating 55
Safety 67
Buy Signal 0.56
Healthcare Equity
Category Rotation: +2.5
AUM: 1.40B
Avg Turnover: 2.69M
Risk 3d forecast
Volatility15.6%
VaR 5th Pctl2.70%
VaR vs Median-3.94%
Reward TTM
Sharpe Ratio0.80
Rel. Str. IBD75.1
Rel. Str. Peer Group7.1 pctl
Character TTM
Beta0.214
Beta Downside0.238
Hurst Exponent0.519
Choppyness64.8%
Drawdowns 3y
Max DD16.01%
CAGR/Max DD0.69
CAGR/Mean DD2.02

Warnings

No concerns identified

Tailwinds

Shakeout
Supp Ema8

Seasonality

Not enough history
Description: HHL Harvest Healthcare Leaders

Harvest Healthcare Leaders Income ETF (HHL), a Canadian-listed ETF, provides exposure to large-cap U.S. healthcare companies and is benchmarked to the Morningstar Global Health GR CAD Index. It seeks income and growth from a sector supported by ongoing demand for medical care and innovation in drugs, treatments, and technologies.

Headlines to Watch Out For
  • Drug approvals and pipeline updates drive healthcare holdings
  • Drug pricing pressure and patent expiries weigh on pharma margins
  • Covered-call premiums support income but limit upside in rallies
What is the price of HHL shares?

As of November 11, 2026, the stock is trading at CAD 7.87 with a total of 223,737 shares traded. Over the past week, the price has changed by +1.88%, over one month by +9.10%, over three months by +7.61% and over the past year by +16.46%.

Current recommended Stop Loss: 7.70 (which is 2.2% or 1.4 ATR below the current price).

Is HHL a buy, sell or hold?

Harvest Healthcare Leaders has no consensus analysts rating.